DK197085A - Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser - Google Patents
Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser Download PDFInfo
- Publication number
- DK197085A DK197085A DK197085A DK197085A DK197085A DK 197085 A DK197085 A DK 197085A DK 197085 A DK197085 A DK 197085A DK 197085 A DK197085 A DK 197085A DK 197085 A DK197085 A DK 197085A
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- derivatives
- pyrimidinon
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title description 4
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 title description 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 description 5
- -1 cyano, formyl Chemical group 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
substituenter udvalgt blandt halogener, alkyl, C^_4 alkanoyl, alkoxy, alkoxykarbonyl, C^_4 alkyl- tio, hydroxy, nitro, cyan, formyl, -NR7R8 (hvor R7 er g hydrogen eller C1-4 alkyl og R hydrogen eller C1-4 alkyl, alkanoyl eller aroyl) eller C^_4 alkyl substitueret med en eller flere hydroxy- eller -NR7R8 grupper og halo- 4 5 genatomer? n tallet 0 eller 1; og R og R uafhængigt af hinanden er hydrogen eller C^g alkyl, eller salte af disse addukter har metafasestandsende egenskaber og god vandopløselighed og kan være nyttige ved bekæmpelse af abnorm celleformering.
Forbindelserne kan fremstilles ved omsætning af pyrimidinonderivater med et stof der afgiver bisulfitioner, eventuelt i nærværelse af en faseoverføringskatalysator. Nyttige mellemprodukter til fremstilling af forbindelser med formel I er forbindelser med formel III
hvor R’ er en gruppe -CH2ORJ (hvor RJ er 4-formylsubsti-tueret fenyl) eller CHjOCHjR^ (hvor R^ er 3- eller 4-metylsubstitueret fenyl eller 3- og 4-klorsubstitueret fenyl) eller salte deraf.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848411291A GB8411291D0 (en) | 1984-05-02 | 1984-05-02 | Chemical compounds |
| GB8411291 | 1984-05-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK197085D0 DK197085D0 (da) | 1985-05-02 |
| DK197085A true DK197085A (da) | 1985-11-03 |
Family
ID=10560411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK197085A DK197085A (da) | 1984-05-02 | 1985-05-02 | Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0160573A3 (da) |
| JP (1) | JPS6110562A (da) |
| DK (1) | DK197085A (da) |
| GB (1) | GB8411291D0 (da) |
| NO (1) | NO851714L (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855466A (en) * | 1987-12-28 | 1989-08-08 | E. R. Squibb & Sons, Inc. | Purinyl cyclobutanes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57136575A (en) * | 1981-01-09 | 1982-08-23 | Nyegaard & Co As | Substituted pyrimidine-2-one compound |
| NO161440C (no) * | 1982-02-24 | 1989-08-16 | Nyegaard & Co As | Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrimidin-2-oner. |
-
1984
- 1984-05-02 GB GB848411291A patent/GB8411291D0/en active Pending
-
1985
- 1985-04-30 NO NO851714A patent/NO851714L/no unknown
- 1985-05-01 EP EP85303102A patent/EP0160573A3/en not_active Withdrawn
- 1985-05-02 JP JP60093948A patent/JPS6110562A/ja active Pending
- 1985-05-02 DK DK197085A patent/DK197085A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK197085D0 (da) | 1985-05-02 |
| JPS6110562A (ja) | 1986-01-18 |
| EP0160573A3 (en) | 1986-11-20 |
| GB8411291D0 (en) | 1984-06-06 |
| EP0160573A2 (en) | 1985-11-06 |
| NO851714L (no) | 1985-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES487537A0 (es) | Un procedimiento para la preparacion de nuevos derivados de quinazolina. | |
| DK173783D0 (da) | Fremgangsmade til fremstilling af imidazo (1,2-alfa)pyridiner | |
| DK380680A (da) | Fremgangsmaade til fremstilling af substituerede oxirancarboxylsyrer | |
| IL66779A (en) | Pyrimidine(triazine)substituted phenylsulfonylurea derivatives,their preparation and their use as herbicides | |
| DK197085A (da) | Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| Liang et al. | Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors | |
| ES2177580T3 (es) | Procedimiento para la preparacion de derivados heterociclicos de fluoralqueniltio. | |
| DK157546C (da) | Analogifremgangsmaade til fremstilling af 3h-nafto(1,2-d)imidazolderivater eller additionssalte deraf med farmaceutisk acceptable syrer. | |
| DK214585A (da) | Fremgangsmaade til fremstilling af imidazorifamyciner | |
| DK3281A (da) | Fremgangsmaade til fremstilling af 2-halogenpyrimid-2-oner eller salte deraf | |
| ATE19242T1 (de) | Substituierte pyrimidin-2-one und deren salze. | |
| DE3060760D1 (en) | 2,2-dichlorocyclopropyl-methyl-phosphoric acid derivatives, process for preparing them and their use in combating pests | |
| CA1324788C (en) | Pyrimidine derivatives | |
| Hisano et al. | A CONVENIENT METHOD FOR SYNTHESIS OF 4 (3H)-QUINAZOLINONES | |
| ES528374A0 (es) | Procedimiento para la obtencion de enantiomeros dextrogiro de derivados de acido fenoxipropionico | |
| IT1150955B (it) | Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono | |
| Aragaki et al. | Facile preparation of TTP series donors by using cyanoethyl groups | |
| Takamizawa et al. | Studies on the Pyrimidine Derivatives. XXVII. Reactions of Amidines with 3-Ethoxy-2-methoxymethylenepropionitrile, 3-Ethoxy-2-ethoxymethoxymethyl-propionitrile, Ethyl 3-Ethoxy-2-methoxymethylenepropionate, and Ethyl 3-Ethoxy-2-ethoxymethoxymethylpropionate. | |
| Makisumi | Studies on Azaindolizine Compounds. XV. The Allyl Rearrangement of 5-Methyl-7-allyloxys-triazolo [1, 5-a] pyrimidine. | |
| Tsubouchi et al. | Synthesis of new thieno [3, 4-c] thiophene derivatives having formyl substituents | |
| EP0194064A3 (en) | Azolyl substituted aralkyl compounds | |
| ES469576A1 (es) | Procedimiento para la preparacion de 5-alquilsulfonil- y 5- alquenilsulfonil-barbituricos. | |
| DK148058C (da) | Analogifremgangsmaade til fremstilling af thiazolderivater eller syreadditionssalte deraf | |
| Edo et al. | CROSS-COUPLING REACTION OF 5-SUBSTITUTED 4-IODOPYRIMIDINES WITH OLEFINS IN THE PRESENCE OF PALLADIUM COMPLEX | |
| Pessolano et al. | Novel nucleophilic substitution of alkyl bromo‐2 (1H)‐pyridones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |
